Jeksar-AM Tablet is a combination antihypertensive medication containing Telmisartan 40 mg and Amlodipine 5 mg, indicated for the management of essential hypertension. Telmisartan, an angiotensin II receptor blocker (ARB), selectively inhibits the binding of angiotensin II to the AT1 receptor, thereby preventing vasoconstriction and aldosterone secretion, resulting in vasodilation and reduction of blood pressure. Amlodipine, a dihydropyridine calcium channel blocker, inhibits the influx of calcium ions into vascular smooth muscle and cardiac muscle, promoting vasodilation and decreasing peripheral vascular resistance. The synergistic action of these agents effectively lowers blood pressure, reducing the risk of cardiovascular events such as stroke, myocardial infarction, and heart failure. Jeksar-AM is particularly beneficial for patients who require combination therapy to achieve target blood pressure levels or those inadequately controlled on monotherapy. The tablet should be administered orally once daily, with or without food, as prescribed by a healthcare professional. Caution is advised in patients with hepatic or renal impairment, and regular monitoring of blood pressure and renal function is recommended. Potential side effects include dizziness, peripheral edema, and hypotension. Jeksar-AM should be used under medical supervision to ensure optimal therapeutic outcomes.